Nina Denne

Credentials: I work on manufacturing and introducing Virus-Free CRISPR-Cas9 canine anti-GD2 Chimeric Antigen Receptor (CAR) T cells into a canine parallel patient population to develop a potential treatment for solid tumors. I am also interested in investigating interactions between immune cells and CAR T cells.